Company intelligence / Profile preview
InduPro
Seattle, Washington, United Statesinduprotx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
InduPro is developing proximity-based therapeutics with their first expected clinical product candidate targeting cancer tissue based on the proximity of co-targeted pairs, currently in preclinical development with an expected IND filing in Q4 2025[4].
- Therapeutic areas
- OncologyImmunology
- Modalities
- Bispecific antibodiesAntibody drug conjugates (ADCs)T cell engagers (TCEs)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on InduPro.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InduPro.